HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vardenafil ameliorates immunologic- and non-immunologic-induced allergic reactions.

Abstract
Cyclic nucleotides, such as cAMP and cGMP, play a protective role in the modulation of the activity of some inflammatory cells in allergic disorders. Their intracellular concentrations are tightly regulated by the phosphodiesterases (PDEs). The protective efficacy of the selective PDE5 inhibitor vardenafil against mast-cell-mediated allergic reactions in murine models has been investigated. Compound 48/80 was used as a direct mast cell degranulator to induce anaphylaxis. Vardenafil (administered orally at 5, 10, 20, 40, and 80 mg/kg body mass) significantly (P < 0.05, n = 12) increased protection against compound-48/80-induced anaphylaxis in mice to 33.33%, 66.67%, 66.67%, 83.33%, and 66.67% respectively compared with the control (vehicle). In passive cutaneous anaphylaxis (PCA) in rats, vardenafil (10 mg/kg body mass) significantly (P < 0.05, n = 6) decreased Evans' blue dye extravasation (4.6-fold). Pre-incubation of isolated rat peritoneal mast cells (RPMCs) with vardenafil (10 and 100 μmol/L) significantly (P < 0.05, n = 6) reduced compound-48/80-induced histamine release by 2.8- and 3-fold, respectively. Moreover, histamine release by immunogenic stimulation of sensitized RPMCs by egg albumin significantly declined following pre-incubation with vardenafil (10 and 100 μmol/L) by 1.94- and 1.99-fold, respectively. In conclusion, inhibition of PDE5 by vardenafil ameliorated immunologic and non-immunologic mast-cell-mediated allergic reactions and reduced histamine release, providing evidence for the potential anti-allergic properties of vardenafil.
AuthorsMohammed S El-Awady, Eman Said
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 92 Issue 3 Pg. 175-80 (Mar 2014) ISSN: 1205-7541 [Electronic] Canada
PMID24593781 (Publication Type: Journal Article)
Chemical References
  • Anti-Allergic Agents
  • Imidazoles
  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Sulfones
  • Triazines
  • p-Methoxy-N-methylphenethylamine
  • Vardenafil Dihydrochloride
Topics
  • Anaphylaxis (drug therapy, immunology)
  • Animals
  • Anti-Allergic Agents (pharmacology, therapeutic use)
  • Cell Degranulation
  • Histamine Release
  • Hypersensitivity (drug therapy, immunology)
  • Imidazoles (pharmacology, therapeutic use)
  • Male
  • Mast Cells (drug effects, immunology)
  • Mice
  • Passive Cutaneous Anaphylaxis (drug effects)
  • Peritoneal Cavity (cytology)
  • Phosphodiesterase 5 Inhibitors (pharmacology, therapeutic use)
  • Piperazines (pharmacology, therapeutic use)
  • Rats
  • Sulfones (pharmacology, therapeutic use)
  • Triazines (pharmacology, therapeutic use)
  • Vardenafil Dihydrochloride
  • p-Methoxy-N-methylphenethylamine (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: